327 related articles for article (PubMed ID: 31146751)
1. Modeling the effect of intratumoral heterogeneity of radiosensitivity on tumor response over the course of fractionated radiation therapy.
Alfonso JCL; Berk L
Radiat Oncol; 2019 May; 14(1):88. PubMed ID: 31146751
[TBL] [Abstract][Full Text] [Related]
2. Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1025-34. PubMed ID: 10571212
[TBL] [Abstract][Full Text] [Related]
3. Further radiobiologic modeling of palliative radiotherapy: use of virtual trials.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):221-9. PubMed ID: 17707276
[TBL] [Abstract][Full Text] [Related]
4. Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy.
Stavreva NA; Warkentin B; Stavrev PV; Fallone BG
Med Phys; 2005 Mar; 32(3):720-5. PubMed ID: 15839343
[TBL] [Abstract][Full Text] [Related]
5. On differences in radiosensitivity estimation: TCP experiments versus survival curves. A theoretical study.
Stavrev P; Stavreva N; Ruggieri R; Nahum A
Phys Med Biol; 2015 Aug; 60(15):N293-9. PubMed ID: 26215150
[TBL] [Abstract][Full Text] [Related]
6. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
Levin-Plotnik D; Hamilton RJ
Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
[TBL] [Abstract][Full Text] [Related]
7. Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity.
Hopewell JW; Nyman J; Turesson I
Int J Radiat Biol; 2003 Jul; 79(7):513-24. PubMed ID: 14530160
[TBL] [Abstract][Full Text] [Related]
8. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
[TBL] [Abstract][Full Text] [Related]
9. The nucleo-shuttling of the ATM protein as a basis for a novel theory of radiation response: resolution of the linear-quadratic model.
Bodgi L; Foray N
Int J Radiat Biol; 2016; 92(3):117-31. PubMed ID: 26907628
[TBL] [Abstract][Full Text] [Related]
10. Clinically validated model predicts the effect of intratumoral heterogeneity on overall survival for non-small cell lung cancer (NSCLC) patients.
Ghaderi N; Jung JH; Odde DJ; Peacock J
Comput Methods Programs Biomed; 2021 Nov; 212():106455. PubMed ID: 34736167
[TBL] [Abstract][Full Text] [Related]
11. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
Brown JM; Carlson DJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):254-62. PubMed ID: 24411596
[TBL] [Abstract][Full Text] [Related]
12. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance.
Yu VY; Nguyen D; Pajonk F; Kupelian P; Kaprealian T; Selch M; Low DA; Sheng K
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):866-75. PubMed ID: 25752402
[TBL] [Abstract][Full Text] [Related]
13. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer.
Carlson DJ; Stewart RD; Li XA; Jennings K; Wang JZ; Guerrero M
Phys Med Biol; 2004 Oct; 49(19):4477-91. PubMed ID: 15552412
[TBL] [Abstract][Full Text] [Related]
15. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
16. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):689-99. PubMed ID: 9635721
[TBL] [Abstract][Full Text] [Related]
17. Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability.
Fakir H; Hlatky L; Li H; Sachs R
Med Phys; 2013 Dec; 40(12):121716. PubMed ID: 24320502
[TBL] [Abstract][Full Text] [Related]
18. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
Sminia P; Schneider CJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell repopulation during conventional and accelerated radiotherapy in the in vitro megacolony culture.
Tarnawski R; Widel M; Skladowski K
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1074-81. PubMed ID: 12605987
[TBL] [Abstract][Full Text] [Related]
20. Dynamic optimization of a linear-quadratic model with incomplete repair and volume-dependent sensitivity and repopulation.
Wein LM; Cohen JE; Wu JT
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1073-83. PubMed ID: 10863081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
